-
Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight
02 Mar 2026 18:00 GMT
… AIS drugs in the clinical trials include Glenzocimab (Acticor Biotech), … trial as an adjunct to standard treatment … 10.4
BRILINTA (ticagrelor): AstraZeneca
11
Emerging … , AptaTargets, NC Medical Research, Prolong Pharmaceuticals, Saillant Therapeutics, …
-
Ticagrelor Not Noninferior to Prasugrel After PCI in Diabetes: JAMA
23 Feb 2026 21:05 GMT
… data have compared these two drugs directly to assess their efficacy … trial aimed to determine noninferiority, with a margin of 5%, between ticagrelor … coronary artery disease undergoing PCI, ticagrelor did not demonstrate non-inferiority …
-
Why electronic medical records are this century’s greatest medical advancement
13 Feb 2026 05:56 GMT
… years ago, allergic to ticagrelor, and creatinine slightly elevated … to a similar drug at another hospital … read their doctor’s notes, and track their medications. Sometimes … true power. Hospitals shared treatment protocols instantly. Researchers analysed …
-
NIH Stops Johnson & Johnson's Blood Thinner Drug Arm In Stroke Trial After Safety Review
11 Feb 2026 20:16 GMT
… trial is to determine if the experimental arms (rivaroxaban or ticagrelor … Prevention?
Rivaroxaban is an FDA-approved anticoagulant used to … instructions to stop the drug.
Individuals who completed the … network.
Other treatment arms in the trial include:
The …
-
Bayer’s Factor XIa inhibitor reduces repeat stroke risk by 26% in pivotal trial
06 Feb 2026 16:54 GMT
… the US Food and Drug Administration (FDA) in February 2022, … the placebo and treatment arms, meeting the trial’s secondary safety … drugs used for acute ischemic stroke are AstraZeneca’s Brilinta (ticagrelor … parent company of Clinical Trials Arena.
Sign up for …
-
<![CDATA[Pharmacists’ Role Expands in Pharmacogenomics and Personalized Cardiometabolic Treatment]]>
04 Feb 2026 20:39 GMT
… achieve treatment goals due to multiple factors, including variation in drug … or ticagrelor (Brilinta).
CPIC provides additional PGx guidance on the statin medication class … on systemic concentrations.8
Clinical Trials and Investigations
Large-scale, …
-
Antiplatelet medications linked to worse outcomes in people hospitalized with a brain bleed
29 Jan 2026 18:04 GMT
… more stronger antiplatelet medications (such as clopidogrel, prasugrel and ticagrelor) in addition … therapy and new generation antiplatelet drugs has improved the lives of … stroke occurs while on these treatments, it is more likely to …
-
A Novel Screening Method to Prioritise Cardiovascular Patients Receiving a Pharmaceutical Care Intervention and the Effects on Patients’ Difficulties with Managing Their Drug Treatment
28 Nov 2025 12:46 GMT
… pharmaceutical care intervention concerning the management of their drug treatment … , and ticagrelor. The … doctor.
Figure 3 Total difficulties with managing their drug treatment … medical knowledge showed difficulties with managing their drug treatment …
-
From Methotrexate Resistance to Biologic and Targeted Pharmacotherapy: A Decade of Phase 4 Clinical Trials Evidence in Rheumatoid Arthritis
08 Jan 2026 14:03 GMT
… . Investigations involving ticagrelor highlighted the intersection … trials and provide important insight into emerging precision medicine … resistant RA.
Vaccination and adjunctive treatment studies broadened … in rheumatoid arthritis. Pharmaceuticals. 2023;16(3 …
-
7 Medications That Don’t Mix Well With Herbal Tea
05 Jan 2026 14:50 GMT
… . They include the following medications:
Eliquis (apixaban)
Pradaxa … (prasugrel)
Brilinta (ticagrelor)
Any herbal medication that can affect bleeding … s effectiveness include:
4. Antidepressants
Antidepressants, including selective serotonin reuptake …
About
© 1995-2026